ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-3.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-30.36%
2024844.31%
2023114.65%
20229.25%
20217.72%
20209.90%
20199.76%
201823.13%
2017-3.54%
2016-72.76%